Dashenlin Pharmaceutical Group Co., Ltd. Class ASSE: 603233

in 2026

· Issued by Dashenlin Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Follow-up Rating Results of "Dashenlin Convertible Bonds” in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Dashenlin Pharmaceutical Group Co., Ltd. Class A

All Dashenlin Pharmaceutical Group Co., Ltd. Class A news releases